-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $55.2M, a 49.7% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $230M, a 75% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $197M, a 83.2% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $107M, a 53.8% increase from 2021.
- Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $69.9M, a 538% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)